Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.

Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.

Which value does Bracco give to education? At ECR2024, Francesca Pelliconi, Strategy & Operations Director, Global Marketing at Bracco Imaging, engaged in a conversation with Guido Gebhardt of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends. 

The Bracco Group announces the newly-created Bracco Japan The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai

What does innovation mean to Bracco? At ECR2024, Fabio Tedoldi, Head of Global Research & Development at Bracco Imaging, engaged in a conversation on Innovation with Mélisande Rouger of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends. 

Bracco and SABI Announce Continued Partnership of the SABI Bracco Mentorship Program Bracco is proud to renew its three-year unrestricted educational grant commitment as the sole partner of the SABI Mentorship Program. The objective of the program is to support the career growth and personal development of SABI members.

Bracco Suisse and Verasonics: a new strategic partnership The collaboration focuses on combining Verasonics' Vantage®️ NXT Research Ultrasound Systems with Bracco's contrast agents to explore improved imaging performance in various research applications.

Blue Earth Diagnostics appoints Marco Campione as Chief Executive Officer Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals.